Next Article in Journal
Characterization of In Vitro 3D Cell Model Developed from Human Hepatocellular Carcinoma (HepG2) Cell Line
Next Article in Special Issue
Novel PET Biomarkers to Disentangle Molecular Pathways across Age-Related Neurodegenerative Diseases
Previous Article in Journal
A Singular and Widespread Group of Mobile Genetic Elements: RNA Circles with Autocatalytic Ribozymes
Previous Article in Special Issue
Extracellular Vesicles in Alzheimer’s and Parkinson’s Disease: Small Entities with Large Consequences
Open AccessArticle

Hearing Loss in Alzheimer’s Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles

1
Molecular and Cellular Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA
2
Carle Neuroscience Institute, Urbana, IL 61801, USA
3
Department of Biology and Schreyer Honors College, Pennsylvania State University, University Park, PA 16802, USA
4
GlaxoSmithKline, Collegeville, PA 19426 USA
5
Department of Mathematics, Statistics and Computer Science, University of Illinois at Chicago, Chicago, IL 60607, USA
*
Author to whom correspondence should be addressed.
Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.
Cells 2020, 9(12), 2556; https://doi.org/10.3390/cells9122556
Received: 21 October 2020 / Revised: 23 November 2020 / Accepted: 24 November 2020 / Published: 28 November 2020
Recent data have found that aging-related hearing loss (ARHL) is associated with the development of Alzheimer’s Disease (AD). However, the nature of the relationship between these two disorders is not clear. There are multiple potential factors that link ARHL and AD, and previous investigators have speculated that shared metabolic dysregulation may underlie the propensity to develop both disorders. Here, we investigate the distribution of serum lipidomic biomarkers in AD subjects with or without hearing loss in a publicly available dataset. Serum levels of 349 known lipids from 16 lipid classes were measured in 185 AD patients. Using previously defined co-regulated sets of lipids, both age- and sex-adjusted, we found that lipid sets enriched in phosphatidylcholine and phosphatidylethanolamine showed a strong inverse association with hearing loss. Examination of biochemical classes confirmed these relationships and revealed that serum phosphatidylcholine levels were significantly lower in AD subjects with hearing loss. A similar relationship was not found in normal subjects. These data suggest that a synergistic relationship may exist between AD, hearing loss and metabolic biomarkers, such that in the context of a pathological state such as AD, alterations in serum metabolic profiles are associated with hearing loss. These data also point to a potential role for phosphatidylcholine, a molecule with antioxidant properties, in the underlying pathophysiology of ARHL in the context of AD, which has implications for our understanding and potential treatment of both disorders. View Full-Text
Keywords: Alzheimer; mild cognitive impairment; hearing loss; presbycusis; phosphatidylcholine; lipidomic Alzheimer; mild cognitive impairment; hearing loss; presbycusis; phosphatidylcholine; lipidomic
Show Figures

Figure 1

MDPI and ACS Style

Llano, D.A.; Issa, L.K.; Devanarayan, P.; Devanarayan, V.; Alzheimer’s Disease Neuroimaging Initiative. Hearing Loss in Alzheimer’s Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles. Cells 2020, 9, 2556.

AMA Style

Llano DA, Issa LK, Devanarayan P, Devanarayan V, Alzheimer’s Disease Neuroimaging Initiative. Hearing Loss in Alzheimer’s Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles. Cells. 2020; 9(12):2556.

Chicago/Turabian Style

Llano, Daniel A.; Issa, Lina K.; Devanarayan, Priya; Devanarayan, Viswanath; Alzheimer’s Disease Neuroimaging Initiative. 2020. "Hearing Loss in Alzheimer’s Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles" Cells 9, no. 12: 2556.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop